# FDA Inspection 1306612 - Alexander E. Drilon, M.D. - March 03, 2026

Source: https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/1636aa08-1220-4cc8-9bd5-040cfad42dab
Source feed: FDA_Inspections

> FDA Inspection 1306612 for Alexander E. Drilon, M.D. on March 03, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306612
- Company Name: Alexander E. Drilon, M.D.
- Inspection Date: 2026-03-03
- Product Type: Human Drugs
- Office Name: New York District Office

## Related Documents

- [FDA Inspection 1209656 - 2023-06-16](https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/bcf8e434-62c0-45da-be1d-680257bd6c47)
- [FDA Inspection 1089078 - 2019-04-26](https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/af626bb4-9417-43d6-98f9-bf2da572b483)
- [FDA Inspection 1055316 - 2018-05-17](https://www.keypedia.com/records/fda_inspections/alexander-e-drilon-md/7eeb5080-1486-4bb4-b05d-bdda892a71db)

Company: https://www.keypedia.com/companies/alexander-e-drilon-md/09292093-df70-41ce-a80b-6e7959abc03b

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d